08/10/2026
🐾 Can a targeted supplement make a visible difference in a dog's everyday movement? To find out what pet parents actually see at home, an 8-week, placebo-controlled field trial was conducted on dogs with visible mobility challenges.
Here is what the real-world data revealed:
✅ 57% of dogs in the KynoSil® group showed improvements in overall mobility, compared to just 20% in the placebo group.
✅ 57% experienced better daily comfort (disability score), vs. 40% receiving a placebo.
✅ 57% saw an increase in daily activity levels, compared to 20% in the placebo group.
🐶 From longer walks to renewed enthusiasm during playtime, real owners reported meaningful changes in daily comfort and quality of life.
Curious about the science behind KynoSil® and how it supports canine joint health?
Contact us today to learn more details and view the full trial findings!
📩 [email protected] | 🌐 www.aprpharma.eu